Rein Therapeutics, Inc. (RNTX)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 4, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence is a request from Rein Therapeutics, Inc. to the SEC for the acceleration of their Registration Statement on Form S-1, seeking to have it declared effective on … | Read Filing EDGAR |
| Sep. 4, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated September 4, 2025, informs Brian Windsor, CEO of Rein Therapeutics, Inc., that the SEC has not reviewed and will not review the company's registration… | Read Filing EDGAR |
| May. 21, 2025 | CORRESP | Neutral/Informational | Moderate | Rein Therapeutics, Inc. has submitted a request for the acceleration of the effective date of its Registration Statement on Form S-3. The company aims for the registration to beco… | Read Filing EDGAR |
| May. 21, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has informed Rein Therapeutics, Inc. that it will not review their registration statement filed on May 16, 2025. The letter emphasizes that the company is responsible for … | Read Filing EDGAR |